More men living longer with incurable prostate cancer, report finds
Men in England diagnosed with incurable advanced prostate cancer are more likely to survive for at least three years than they were a decade ago, according to an analysis by the London School of Hygiene & Tropical Medicine (LSHTM) and partners.
A recent analysis reveals that more men in England are surviving longer with advanced, incurable prostate cancer, according to a study conducted by the London School of Hygiene & Tropical Medicine (LSHTM) and partners. Between 2015 and 2022, the proportion of men who died within three years after diagnosis decreased from 56% to 47%.
This improvement is attributed to new treatments becoming accessible through the National Health Service (NHS) and better care organization, including earlier diagnosis and more rapid access to specialist teams. Despite these advancements, nearly half of men diagnosed with incurable prostate cancer still do not survive beyond three years, and not all those who could benefit are receiving the available treatments.
Experts emphasize the importance of continued improvements in both treatment development and their timely adoption in clinical practice.
Written by urgent.news from Medical Xpress's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
